|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
U.S. Squeezes Out A Few Million More Flu Vaccines
10/19/2005 5:11:48 PM
U.S. health officials, stung by political attacks after losing 40 percent of the flu shot supply, got a small break on Tuesday as one vaccine supplier announced it had squeezed out an extra 2.6 million doses.
But the firestorm over blame for the loss of 40 million doses, which has prompted lines of worried elderly people at pharmacies across the country, raged on with just two weeks to go before the presidential election.
President Bush told senior citizens in Florida that he was doing all he could to ensure they get flu shots and accused his Democratic rival, Massachusetts Sen. John Kerry, of playing fear politics by raising the vaccine shortage.
The extra production announced by vaccine maker Aventis-Pasteur will give the United States a total 58 million influenza shots this season, Health and Human Services Secretary Tommy Thompson told a news conference.
With MedImmune's 2 million doses of inhaled FluMist vaccine, this provides 60 million doses total for the year, he said.
But the country is still far short of the 100 million doses that had been planned, after Chiron Corp. lost the license for a British vaccine plant on Oct. 5.
|
|
|
|
|
|
|
|
|
|
|